Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter–defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ...

A novel, water-resistant patch-wearable cardioverter-defibrillator (P-WCD) is safe and effective for patients at risk for sudden cardiac arrest, according to a study published in the Aug. 6 issue of ...

The increasing effectiveness of pharmacological and non-pharmacological treatment of heart failure has contributed to increased life expectancy and lifespan in patients with implantable ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

An entirely subcutaneous implantable cardioverter defibrillator (ICD) differs from a transvenous ICD in that a single lead is placed subcutaneously. This single lead comprises 2 sensing ring ...

Exercise plays an important role in rehabilitation after implantation of a pacemaker or other cardioverter defibrillator because it will counteract the deconditioning that occurred prior to ...

DENVER — Implanted stimulators halt thousands of cardiac arrests annually by delivering sharp jolts of electricity to weakened hearts that have begun beating dangerously rapidly or erratically. But it ...

Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra ™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE ® Wearable ...

The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. This has been issued for four weeks’ ...